FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009829205> ?p ?o ?g. }

• W2009829205 endingPage "e1041" @default.
• W2009829205 startingPage "e1041" @default.
• W2009829205 abstract "Leprosy Type 1 reactions are a major cause of nerve damage and the preventable disability that results. Type 1 reactions are treated with oral corticosteroids and there are few data to support the optimal dose and duration of treatment. Type 1 reactions have a Th1 immune profile: cells in cutaneous and neural lesions expressing interferon-γ and interleukin-12. Methylprednisolone has been used in other Th1 mediated diseases such as rheumatoid arthritis in an attempt to switch off the immune response and so we investigated the efficacy of three days of high dose (1 g) intravenous methylprednisolone at the start of prednisolone therapy in leprosy Type 1 reactions and nerve function impairment.Forty-two individuals were randomised to receive methylprednisolone followed by oral prednisolone (n = 20) or oral prednisolone alone (n = 22). There were no significant differences in the rate of adverse events or clinical improvement at the completion of the study. However individuals treated with methylprednisolone were less likely than those treated with prednisolone alone to experience deterioration in sensory function between day 29 and day 113 of the study. The study also demonstrated that 50% of individuals with Type 1 reactions and/or nerve function impairment required additional prednisolone despite treatment with 16 weeks of corticosteroids.The study lends further support to the use of more prolonged courses of corticosteroid to treat Type 1 reactions and the investigation of risk factors for the recurrence of Type 1 reaction and nerve function impairment during and after a corticosteroid treatment.Controlled-Trials.com ISRCTN31894035." @default.
• W2009829205 created "2016-06-24" @default.
• W2009829205 creator A5002991261 @default.
• W2009829205 creator A5007115319 @default.
• W2009829205 creator A5008271550 @default.
• W2009829205 creator A5016138432 @default.
• W2009829205 creator A5041144908 @default.
• W2009829205 creator A5042870699 @default.
• W2009829205 creator A5051700048 @default.
• W2009829205 creator A5055522113 @default.
• W2009829205 creator A5068187868 @default.
• W2009829205 creator A5075396441 @default.
• W2009829205 creator A5088021595 @default.
• W2009829205 date "2011-04-12" @default.
• W2009829205 modified "2023-10-13" @default.
• W2009829205 title "A Phase Two Randomised Controlled Double Blind Trial of High Dose Intravenous Methylprednisolone and Oral Prednisolone versus Intravenous Normal Saline and Oral Prednisolone in Individuals with Leprosy Type 1 Reactions and/or Nerve Function Impairment" @default.
• W2009829205 cites W155774906 @default.
• W2009829205 cites W1963992460 @default.
• W2009829205 cites W1977489783 @default.
• W2009829205 cites W2003640159 @default.
• W2009829205 cites W2009060857 @default.
• W2009829205 cites W2055857629 @default.
• W2009829205 cites W2084785618 @default.
• W2009829205 cites W2084900898 @default.
• W2009829205 cites W2100100854 @default.
• W2009829205 cites W2102897270 @default.
• W2009829205 cites W2142960568 @default.
• W2009829205 cites W2147149796 @default.
• W2009829205 cites W2181848803 @default.
• W2009829205 cites W2230624986 @default.
• W2009829205 cites W2274312710 @default.
• W2009829205 cites W2274351859 @default.
• W2009829205 cites W2290751008 @default.
• W2009829205 cites W2417094765 @default.
• W2009829205 doi "https://doi.org/10.1371/journal.pntd.0001041" @default.
• W2009829205 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3075223" @default.
• W2009829205 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21532737" @default.
• W2009829205 hasPublicationYear "2011" @default.
• W2009829205 type Work @default.
• W2009829205 sameAs 2009829205 @default.
• W2009829205 citedByCount "36" @default.
• W2009829205 countsByYear W20098292052012 @default.
• W2009829205 countsByYear W20098292052014 @default.
• W2009829205 countsByYear W20098292052015 @default.
• W2009829205 countsByYear W20098292052016 @default.
• W2009829205 countsByYear W20098292052017 @default.
• W2009829205 countsByYear W20098292052019 @default.
• W2009829205 countsByYear W20098292052020 @default.
• W2009829205 countsByYear W20098292052021 @default.
• W2009829205 countsByYear W20098292052022 @default.
• W2009829205 countsByYear W20098292052023 @default.
• W2009829205 crossrefType "journal-article" @default.
• W2009829205 hasAuthorship W2009829205A5002991261 @default.
• W2009829205 hasAuthorship W2009829205A5007115319 @default.
• W2009829205 hasAuthorship W2009829205A5008271550 @default.
• W2009829205 hasAuthorship W2009829205A5016138432 @default.
• W2009829205 hasAuthorship W2009829205A5041144908 @default.
• W2009829205 hasAuthorship W2009829205A5042870699 @default.
• W2009829205 hasAuthorship W2009829205A5051700048 @default.
• W2009829205 hasAuthorship W2009829205A5055522113 @default.
• W2009829205 hasAuthorship W2009829205A5068187868 @default.
• W2009829205 hasAuthorship W2009829205A5075396441 @default.
• W2009829205 hasAuthorship W2009829205A5088021595 @default.
• W2009829205 hasBestOaLocation W20098292051 @default.
• W2009829205 hasConcept C126322002 @default.
• W2009829205 hasConcept C141071460 @default.
• W2009829205 hasConcept C197934379 @default.
• W2009829205 hasConcept C2776715498 @default.
• W2009829205 hasConcept C2776804153 @default.
• W2009829205 hasConcept C2777575956 @default.
• W2009829205 hasConcept C2780372218 @default.
• W2009829205 hasConcept C42219234 @default.
• W2009829205 hasConcept C71924100 @default.
• W2009829205 hasConcept C90924648 @default.
• W2009829205 hasConceptScore W2009829205C126322002 @default.
• W2009829205 hasConceptScore W2009829205C141071460 @default.
• W2009829205 hasConceptScore W2009829205C197934379 @default.
• W2009829205 hasConceptScore W2009829205C2776715498 @default.
• W2009829205 hasConceptScore W2009829205C2776804153 @default.
• W2009829205 hasConceptScore W2009829205C2777575956 @default.
• W2009829205 hasConceptScore W2009829205C2780372218 @default.
• W2009829205 hasConceptScore W2009829205C42219234 @default.
• W2009829205 hasConceptScore W2009829205C71924100 @default.
• W2009829205 hasConceptScore W2009829205C90924648 @default.
• W2009829205 hasIssue "4" @default.
• W2009829205 hasLocation W20098292051 @default.
• W2009829205 hasLocation W20098292052 @default.
• W2009829205 hasLocation W20098292053 @default.
• W2009829205 hasLocation W20098292054 @default.
• W2009829205 hasLocation W20098292055 @default.
• W2009829205 hasOpenAccess W2009829205 @default.
• W2009829205 hasPrimaryLocation W20098292051 @default.
• W2009829205 hasRelatedWork W1972649044 @default.
• W2009829205 hasRelatedWork W1978167968 @default.
• W2009829205 hasRelatedWork W2049462622 @default.
• W2009829205 hasRelatedWork W2055857629 @default.
• W2009829205 hasRelatedWork W2090116559 @default.
• W2009829205 hasRelatedWork W2124479292 @default.

• next